Dl-3-n-Butylphthalide enhances the survival of rat bone marrow stem cells via a reactive oxygen species mediated Erk1/2 signaling pathway
Brain Research · 2025
DOI: 10.1016/j.brainres.2025.149551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2025. Verfasst von Xianjin Ke und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, PR China. Hauptthemen laut MEDLINE: Benzofurans, Reactive Oxygen Species, MAP Kinase Signaling System, Bone Marrow Cells. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Survival of bone marrow stem cells (BMSCs) is crucial for successful bone marrow transplantation. However, the underlying molecular mechanisms remain inadequately understood. Our previous research has demonstrated that dl-3-n-butylphthalide (NBP) can protect rat BMSCs (rBMSCs) from cell death via its antioxidative properties and by activating the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway. The findings suggest that the PI3K/Akt pathway may be one of the primary targets through which NBP exert its protective effects. In this study, we explored an additional signaling pathway to further elucidate the molecular mechanisms involved in NBP-mediated protection against oxidative stress injury in rBMSCs. Oxidative stress was induced in rBMSCs using hydrogen peroxide (H2O2), imitating the cerebral ischemia microenvironment surrounding transplanted cells in vitro. The protective effects of NBP on rBMSCs against apoptosis were observed, achieving by decreasing the level of reduce reactive oxygen species (ROS) and malondialdehyde (MDA) while simultaneously increasing the concentration of superoxide dismutase (SOD). Notably, these protective effects were partially inhibited by U0126, an extracellular signal-regulated kinase1/2 (Erk1/2) inhibitor, which enhanced the suppression of NBP's antiapoptotic effects. Our results indicated that NBP could protect rBMSCs from apoptosis through modulation of ROS/Erk pathways. Further investigations are warranted to clarify the unknown mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, PR China.
- Department of Electrophysiology Laboratory, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu 223300, PR China.
- Department of Neurology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu 223300, PR China.
- Department of Stomatology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, PR China.
- Department of Cardiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu 223300, PR China. Electronic address: wofcardio96@126.com.
- Department of Neurology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu 223300, PR China; Department of Neurology, The Huaian Clinical College of Xuzhou Medical University,…
Zitieren
APA
Ke, X., Wu, Q., Cai, S., Wang, C., Lu, T., Sun, Z., Tian, X., Wu, X., Wang, B., & Sun, B. (2025). Dl-3-n-Butylphthalide enhances the survival of rat bone marrow stem cells via a reactive oxygen species mediated Erk1/2 signaling pathway. Brain Research. https://doi.org/10.1016/j.brainres.2025.149551
Vancouver
Ke X, Wu Q, Cai S, Wang C, Lu T, Sun Z, et al. Dl-3-n-Butylphthalide enhances the survival of rat bone marrow stem cells via a reactive oxygen species mediated Erk1/2 signaling pathway. Brain Research. 2025. doi:10.1016/j.brainres.2025.149551
BibTeX
@article{Ke2025,
author = {Ke, Xianjin and Wu, Qianqian and Cai, Shikun and Wang, Chengyun and Lu, Ting and Sun, Zhenjie and Tian, Xiangyang and Wu, Xian and Wang, Bingjian and Sun, Bo},
title = {Dl-3-n-Butylphthalide enhances the survival of rat bone marrow stem cells via a reactive oxygen species mediated Erk1/2 signaling pathway},
journal = {Brain Research},
year = {2025},
doi = {10.1016/j.brainres.2025.149551}
}
EUVIMED